In order to facilitate the harmonisation of the clinical development of placental malaria vaccine candidates, EVI organised joint workshops in 2014 in Paris and Brussels, the proceedings of which are now available in Malaria Journal

VAC2VAC is a wide ranging collaborative research project funded by IMI2 which aims to develop and validate quality testing approaches for both human and veterinary vaccines using non animal methods.  

The initiative  that  started  on  1  March 2016 aims  to  provide  the  data  to  support  the ‘Consistency Approach’ for quality control of established vaccines.  More information on the project and on the participants can now be found under the following

The Committee for Medicinal Products for Human Use (CHMP) of EMA has recently published the following:  Questions and answers on the withdrawal of the CPMP Note for guidance on preclinical pharmacological and toxicological testing of vaccines (CPMP/SWP/465).

The EVI 2015 Annual Report provides a detailed insight into all of EVI's activities, projects, important meetings etc.  We hope you will find it not only enlightening, but interesting reading.

New article published on 30 August 2016 in Malaria Journal emanating from EVI project AMA1

The Royal College of Surgeons in Ireland (RCSI) Strategic Academic Recruitment (StAR) currently has a Research Lecturer Recruitment Campaign with deadline 13 Setpember.

The MAlaria Research CApacity Development consortium (MARCAD) is currently calling for applications for 5 PhD and 10 post Postdoctoral Fellowships. Deadline: 31 August 2016

A publication emerging from the InnoMalVac project entitled "Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system" has recently been published in Nature/scientific reports.

SAP SE which stands for “System analyses and Programme networking; Systems, Applications & Products in Data Processing” has published a news blog on diseases of poverty together with EVI, which is being made available to German/UK/US news outlets by SAP.  EVI has adopted SAP Business ByDesign for its financial management, and is very grateful for the generous support of SAP.

German speakers please click here


On a sad note, EVI brings news of the death of Dr Egeruan Babatunde Imoukuede. Tunde, as he was known to his friends, joined EVI in 2005 as Clinical and Regulatory Affairs Director.  He left in 2013 to work for the Jenner Institute  at University of Oxford.  Babatunde was a brilliant advocate for the battle against diseases of poverty. During all the years he was fighting for his life, he was an example of resilience and professionalism.  He will be remembered at EVI for his persistent committment to research and development of malaria vaccines.